Ossiam lowered its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 73.7% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,573 shares of the pharmacy operator’s stock after selling 7,200 shares during the period. Ossiam’s holdings in Walgreens Boots Alliance were worth $141,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in WBA. Nelson Roberts Investment Advisors LLC purchased a new position in Walgreens Boots Alliance in the 1st quarter worth approximately $25,000. Meridian Wealth Management LLC purchased a new position in Walgreens Boots Alliance in the 1st quarter worth approximately $25,000. Trustcore Financial Services LLC purchased a new position in Walgreens Boots Alliance in the 1st quarter worth approximately $31,000. Sageworth Trust Co purchased a new position in Walgreens Boots Alliance in the 2nd quarter worth approximately $27,000. Finally, Weaver Consulting Group purchased a new position in Walgreens Boots Alliance in the 1st quarter worth approximately $27,000. 59.80% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ WBA traded up $0.19 during mid-day trading on Friday, hitting $55.75. 1,066,488 shares of the stock traded hands, compared to its average volume of 4,468,094. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.37 and a current ratio of 0.76. Walgreens Boots Alliance Inc has a 52 week low of $49.03 and a 52 week high of $86.31. The company has a market cap of $51.37 billion, a price-to-earnings ratio of 9.26, a PEG ratio of 1.42 and a beta of 0.88. The stock has a fifty day moving average price of $52.32 and a 200-day moving average price of $55.15.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.42 by $0.05. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The company had revenue of $34.59 billion for the quarter, compared to analyst estimates of $34.52 billion. During the same period in the previous year, the company posted $1.53 earnings per share. The firm’s revenue was up .7% on a year-over-year basis. As a group, sell-side analysts predict that Walgreens Boots Alliance Inc will post 5.98 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Thursday, September 12th. Investors of record on Tuesday, August 20th were given a dividend of $0.458 per share. The ex-dividend date was Monday, August 19th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. This represents a $1.83 annualized dividend and a dividend yield of 3.29%. Walgreens Boots Alliance’s payout ratio is currently 30.40%.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the business’s stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total value of $10,869,505.04. Following the sale, the chief accounting officer now directly owns 357,851 shares of the company’s stock, valued at $18,064,318.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 15.73% of the company’s stock.

A number of equities analysts have commented on the company. Morgan Stanley decreased their price target on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating on the stock in a research note on Friday, August 23rd. Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating and set a $53.00 price objective on the stock. in a research report on Monday, June 10th. Deutsche Bank started coverage on Walgreens Boots Alliance in a research report on Thursday. They issued a “sell” rating on the stock. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Wednesday. Finally, JPMorgan Chase & Co. cut their price objective on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating on the stock in a research report on Friday, June 28th. Seven equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $63.65.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

See Also: When can a hold rating present a buying opportunity?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.